Bright Minds Biosciences (DRUG) Net Cash Flow (2020 - 2026)
Bright Minds Biosciences (DRUG) posted Net Cash Flow of $159.9 million for Q1 2026, up 2842.94% on a QoQ basis from $5.4 million in Q4 2025, and up 8553.58% year-over-year from $1.8 million in Q1 2025.
Bright Minds Biosciences (DRUG) Net Cash Flow (2020 - 2026) Analysis & Trends
Bright Minds Biosciences' Net Cash Flow history runs 7 years deep, the most recent figure standing at $159.9 million for Q1 2026.
- Quarterly Net Cash Flow rose 8553.58% year-over-year to $159.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $180.4 million (up 379.88% YoY) and the FY2025 annual result came in at $55.9 million, up 7429.91% from the prior year.
- Net Cash Flow was $159.9 million for Q1 2026 at Bright Minds Biosciences, up from $5.4 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $159.9 million in Q1 2026 and bottomed at -$15.3 million in Q3 2022.
- A 5-year average of $12.1 million and a median of $1.2 million in 2023 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2025 — Net Cash Flow sank 4178.12% — and 2026, when it surged 8553.58%.
- Bright Minds Biosciences' Net Cash Flow stood at $3.6 million in 2022, then plunged by 65.53% to $1.2 million in 2023, then surged by 2968.79% to $38.3 million in 2024, then slumped by 85.83% to $5.4 million in 2025, then jumped by 2842.94% to $159.9 million in 2026.
- Business Quant data shows DRUG's Net Cash Flow at $159.9 million in Q1 2026, $5.4 million in Q4 2025, and $23.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Bright Minds Biosciences | 498.53 Mn | 498.53 Mn | - | 159.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 159.86 Mn |
| Mar 31, 2026 | 159.86 Mn |
| Dec 31, 2025 | 5.43 Mn |
| Dec 31, 2025 | 5.43 Mn |
| Sep 30, 2025 | 23.29 Mn |
| Sep 30, 2025 | 23.29 Mn |
| Jun 30, 2025 | -8.20 Mn |
| Jun 30, 2025 | -8.20 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 38.32 Mn |
| Dec 31, 2024 | 38.32 Mn |
| Sep 30, 2024 | -2.39 Mn |
| Sep 30, 2024 | -2.39 Mn |
| Jun 30, 2024 | -191,644.37 |
| Jun 30, 2024 | -191,644.37 |
| Mar 31, 2024 | 581,172.60 |
| Mar 31, 2024 | 581,172.60 |
| Dec 31, 2023 | 1.25 Mn |
| Dec 31, 2023 | 1.25 Mn |